TCR-based Therapies Market Research Report 2021
16 juil. 2021 04h58 HE
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030"...
Outlook on the Oncolytic Virus Immunotherapy Global Market to 2026 - Key Drivers and Inhibitors
20 oct. 2020 04h08 HE
|
Research and Markets
Dublin, Oct. 20, 2020 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market, Dosage, Price & Clinical Trials Outlook 2026" report has been added to ResearchAndMarkets.com's...
Global Immuno-Oncology Diagnostics Markets 2020-2024: Focus on Biomarkers and the Next Five Years
01 oct. 2020 07h29 HE
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "The Race for Biomarkers Market Forecasts for Immuno-Oncology Diagnostics, With Exutive and Consultant Guides and including Customized Forecasting and...
OTraces’ TME Cancer Blood Test Presentation at Innovation Challenge Spurs Investor Interest from JP Morgan Healthcare Conference Participants
11 janv. 2018 13h39 HE
|
OTraces, Inc.
SAN FRANCISCO and BALTIMORE, Jan. 11, 2018 (GLOBE NEWSWIRE) -- OTraces Inc., a Sykesville, Maryland-based cancer diagnostics company with a unique patented and patent-pending blood test which...
Biothera Announces Three Presentations at Upcoming American Association for Cancer Research (AACR) Annual Meeting
27 mars 2017 11h00 HE
|
Biothera Pharmaceuticals, Inc.
EAGAN, Minn., March 27, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals Inc. announced today that it will present three scientific posters at the American Association for Cancer Research (AACR)...
National Brain Tumor Society Cites Ten Reasons for Brain Tumor Community Excitement in 2017
10 janv. 2017 17h35 HE
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - January 10, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community, enters 2017 with greater enthusiasm about its mission...